CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Altrazeal Life Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Altrazeal Life Sciences Inc
4410 Beltway Dr
Phone: (214) 905-5145p:214 905-5145 ADDISON, TX  75001  United States Ticker: ULURULUR

This company ceased filing statements with the SEC on 3/1/2019.

Business Summary
Altrazeal Life Sciences Inc., formerly ULURU Inc., is engaged in offering advanced topical solutions. The Company is a specialty medical technology company that is involved in developing and commercializing wound care and drug delivery systems based on its patented technologies. Its patented technology platforms include Altrazeal and OraDisc. Altrazeal is a new class of material designed to optimize the wound bed environment and accelerate healing. When applied to a moist wound, the powder interacts with the wound exudate and hydrates. OraDisc is a water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort and provides erosion rates to deliver therapeutics over different time intervals.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201812/31/2017YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Bradley J.Sacks 11/20/2015 7/28/2015
Chief Executive Officer, Director Vaidehi A.Shah 2/27/2017 2/27/2017
Acting Chief Financial Officer P.K.Ramachandran 65 12/3/2018 12/3/2018
Director ArindamBose 70 2/27/2017 2/27/2017

Business Names
Business Name
Cardinia Acquisition Corp.
ULUR
ULURD
ULURU Delaware Inc.

General Information
Number of Employees: 7 (As of 12/31/2014)
Outstanding Shares: 20,134,943 (As of 3/23/2020)
Shareholders: 56
Stock Exchange: OTC
Federal Tax Id: 412118656
Fax Number: (214) 905-5130


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 24, 2023